In one study, inhibition of the three major protein products (BimEL, BimS, and BimL) resulted in different levels of resistance to glucocorticoid treatment in acute lymphoblastic leukemia cells[74]. The gene discussed is BCL2L11; the disease is acute lymphoblastic leukemia.